Clinical Stage IIB Cutaneous Melanoma AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01327 | Cefazolin | 1 | Active Not Recruiting | 1 |
| DB10791 | Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) | 1 | Recruiting | 1 |
| DB14452 | Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated) | 1 | Recruiting | 1 |
| DB10794 | Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) | 1 | Recruiting | 1 |
| DB14454 | Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated) | 1 | Recruiting | 1 |
| DB06186 | Ipilimumab | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB14851 | Relatlimab | 1 | Recruiting | 1 |
| DB14681 | Cortisone | 1 / 2 | Recruiting | 1 |
| DB00065 | Infliximab | 1 / 2 | Recruiting | 1 |
| DB00959 | Methylprednisolone | 1 / 2 | Recruiting | 1 |
| DB00635 | Prednisone | 1 / 2 | Recruiting | 1 |
| DB09033 | Vedolizumab | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |